Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Phase II Randomized Control Clinical Trial

Condition:   Local Advanced High Risk Nasopharyngeal Carcinoma
Interventions:   Drug: IMRT combine with cisplatin concurrent chemotherapy;   Drug: IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
Sponsors:   Zhao Chong;   First People's Hospital of Foshan;   Guangzhou General Hospital of Guangzhou Military Command
Recruiting - verified February 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1ozosbK
via IFTTT